Malchoff C D, Orth D N, Abboud C, Carney J A, Pairolero P C, Carey R M
Department of Medicine, University of Virginia Medical Center, Charlottesville 22901.
Am J Med. 1988 Apr;84(4):760-4. doi: 10.1016/0002-9343(88)90116-7.
Cushing's syndrome due to bronchial carcinoid tumors that secrete adrenocorticotropin (ACTH) may be difficult to distinguish from pituitary Cushing's disease, since the responses to dexamethasone and metyrapone are sometimes similar. Recently, the ACTH and cortisol responses to ovine corticotropin-releasing factor (oCRF) have been shown to be different in pituitary Cushing's disease than in Cushing's syndrome due to other causes. It is not known if the response to oCRF can distinguish pituitary Cushing's disease from those ACTH-secreting bronchial carcinoid tumors that respond to dexamethasone and metyrapone. A case of Cushing's syndrome due to an ACTH-secreting bronchial carcinoid is described in which the responses to dexamethasone, metyrapone, and oCRF were indistinguishable from the responses observed in pituitary Cushing's disease. A bronchial carcinoid tumor should be considered even when responses to dexamethasone, metyrapone, and oCRF suggest pituitary Cushing's disease.
由分泌促肾上腺皮质激素(ACTH)的支气管类癌瘤引起的库欣综合征,可能难以与垂体性库欣病相区分,因为对地塞米松和甲吡酮的反应有时相似。最近研究表明,垂体性库欣病患者对羊促肾上腺皮质激素释放因子(oCRF)的ACTH和皮质醇反应,与其他原因所致库欣综合征患者不同。目前尚不清楚,oCRF反应能否区分垂体性库欣病与那些对地塞米松和甲吡酮有反应的分泌ACTH的支气管类癌瘤。本文描述了一例由分泌ACTH的支气管类癌引起的库欣综合征病例,其对地塞米松、甲吡酮和oCRF的反应与垂体性库欣病患者的反应难以区分。即使对地塞米松、甲吡酮和oCRF的反应提示垂体性库欣病,也应考虑支气管类癌瘤的可能。